(2R)-2-[[(2R)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]pentanedioic acid


Chemical Name: (2R)-2-[[(2R)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]pentanedioic acid
CAS Number: 36099-95-3
Product Number: AG007BE3(AGN-PC-04XHQ2)
Synonyms:
MDL No: MFCD00037964
Molecular Formula: C16H19N3O5
Molecular Weight: 333.3392

Identification/Properties


Computed Properties
Molecular Weight:
333.344g/mol
XLogP3:
-2.6
Hydrogen Bond Donor Count:
5
Hydrogen Bond Acceptor Count:
6
Rotatable Bond Count:
8
Exact Mass:
333.132g/mol
Monoisotopic Mass:
333.132g/mol
Topological Polar Surface Area:
146A^2
Heavy Atom Count:
24
Formal Charge:
0
Complexity:
484
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
2
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information


GHS Pictogram:
N/A
Signal Word:
UN#:
-
Hazard Statements:
-
Precautionary Statements:
Class:
-
Packing Group:
-

NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



H-Trp-Glu-OH, a peptide derivative, serves as a versatile building block in chemical synthesis, particularly in the field of peptide chemistry and pharmaceutical research. With its unique structure incorporating both tryptophan (Trp) and glutamic acid (Glu) residues, this compound offers diverse applications and benefits in the creation of peptides and small organic molecules.One of the key applications of H-Trp-Glu-OH is its utility as a starting material for the synthesis of bioactive peptides. By incorporating this compound into peptide sequences, researchers can design and develop new peptide-based therapeutics with enhanced stability, bioavailability, and target specificity. Moreover, the presence of the tryptophan and glutamic acid moieties in H-Trp-Glu-OH can impart desirable biological activities to the resulting peptides, making them potential candidates for drug discovery and development.Additionally, H-Trp-Glu-OH can be utilized in the preparation of peptide mimetics and peptidomimetics, which are non-peptidic compounds designed to mimic the structural and functional properties of natural peptides. These mimetics often exhibit improved pharmacokinetic profiles and therapeutic potential compared to traditional peptides, making them valuable tools in drug design and optimization.Overall, the strategic incorporation of H-Trp-Glu-OH into chemical synthesis processes enables the generation of novel peptide-based compounds with diverse biological activities and pharmacological properties, holding significant promise for advancing research and innovation in the pharmaceutical industry.